Pediatric Hematology and Oncology
Leading citation impact metric from Clarivate Journal Citation Reports
38 papers with at least that number of citations each
State Council for Professorship (HĐGSNN) Scoring
Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)
HĐGSNN Score History
By article publication year| Year | Max Score | Evaluation Details | Source |
|---|---|---|---|
| 2026 | 1.50đ | WoS Q3(IF: 1.4) | 🔵 Computed |
| 2025 | 1.50đ | WoS Q3(IF: 1.2) | 🔵 Computed |
| 2024 | 1.50đ | WoS Q3(IF: 1.2) | 🔵 Computed |
| 2023 | 1.50đ | WoS Q3(IF: 1.7) | 🔵 Computed |
| 2022 | 1.50đ | WoS Q3(IF: 2.07) | 🔵 Computed |
| 2021 | 1.50đ | WoS Q3(IF: 1.969) | 🔵 Computed |
| 2020 | 1.50đ | WoS Q3(IF: 1.232) | 🔵 Computed |
| 2019 | 1.50đ | WoS Q3(IF: 1.041) | 🔵 Computed |
| 2018 | 1.50đ | WoS Q3(IF: 1.154) | 🔵 Computed |
Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.
Aims & Scope
PHO: Pediatric Hematology and Oncology covers all aspects of research and patient management within the area of blood disorders and malignant diseases of childhood. Our goal is to make PHO: Pediatric Hematology and Oncology the premier journal for the international community of clinicians and scientists who together aim to define optimal therapeutic strategies for children and young adults with cancer and blood disorders. The journal supports articles that address research in diverse clinical settings, exceptional case studies/series that add novel insights into pathogenesis and/or clinical care, and reviews highlighting discoveries and challenges emerging from consortia and conferences. Clinical studies as well as basic and translational research reports regarding cancer pathogenesis, genetics, molecular diagnostics, pharmacology, stem cells, molecular targeting, cellular and immune therapies and transplantation are of interest. Papers with a focus on supportive care, late effects and on related ethical, legal, psychological, social, cultural, or historical aspects of these fields are also appreciated. Reviews on important developments in the field are welcome. Articles from scientists and clinicians across the international community of Pediatric Hematology and Oncology are considered for publication. The journal is not dependent on or connected with any organization or society. All submissions undergo rigorous peer review prior to publication. Our Editorial Board includes experts in Pediatric Hematology and Oncology representing a wide range of academic and geographic diversity.
SCImago & Scopus Journal Intelligence
Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact
Weighted prestige citation metric per document indexed in the Scopus database.
Measures cumulative publication volume and citation impact.
Average citations received per document published in the 2-year window.
Estimated Article Processing Charge for Open Access publication.
Scopus 3-Year Publication & Citation Window
Aggregated from Scopus database across the 3-year SJR evaluation window.
Societal Impact & Inclusivity (SCImago)
Citations in government and international policy documents
Percentage of female authors published in the journal
Real-world societal policy reach and author gender diversity tracked by SCImago.
Scopus Subject Categories
Chinese Academy of Sciences (CAS) Classification
Major / minor zone classification and CAS Early Warning List history
Publishing & Editorial Information
Detailed publisher, peer-review turnaround, and publication cycle specifications
WoS Categories & Quartiles
Detailed JCR / JCI category rankings and quartile breakdown from Clarivate
| Category | Index | Rank | Quartile |
|---|---|---|---|
HEMATOLOGY | JCRSCIE | 78/103 | Q4 |
ONCOLOGY | JCRSCIE | 287/333 | Q4 |
PEDIATRICS | JCRSCIE | 112/190 | Q3 |
HEMATOLOGY | JCISCIE | 76/103 | Q3 |
ONCOLOGY | JCISCIE | 279/333 | Q4 |
PEDIATRICS | JCISCIE | 146/190 | Q4 |
Annual Historical Statistics & Publications
Track annual publication volume, total citations, and Impact Factor evolution
| Year | Impact Factor | Articles / Year | Total Citations |
|---|---|---|---|
| 2026 | — | 19 | 1 |
| 2025 | 1.2 | 32 | 24 |
| 2024 | 1.2 | 42 | 67 |
| 2023 | 1.7 | 53 | 166 |
| 2022 | 2.07 | 75 | 370 |
| 2021 | 1.969 | 93 | 513 |
| 2020 | 1.232 | 86 | 672 |
| 2019 | 1.041 | 75 | 814 |
| 2018 | 1.154 | 54 | 612 |
| 2017 | — | 53 | 945 |
| 2016 | — | 54 | 846 |
| 2015 | — | 42 | 623 |
Journal Metrics & Citation Visualizations
Impact Factor Trend (2018–2024)
Clarivate IF trend for Pediatric Hematology and Oncology
Total Cites vs Self-Cites
Evaluation of scholarly independence and citation reach
Citations per Document
Citation metric windows across 2, 3, and 4 years
Similar Journals in Discipline
Journals in the same research field with comparable impact metrics